Trial intelligence / Profile preview

Insulin Glargine on EPCs in Type 2 Diabetes

NCT00523393Phase 4Unknown

Sponsor
Heidelberg University
Start
Aug 2007
Primary completion
Dec 2009
Countries
1
01

Overview

A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Heidelberg University. Status: unknown.

02

Drugs

insulin glargine
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00523393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00523393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call